The 2022 allergy season outlook

For many U.S. shoppers, springtime doesn’t just mean warmer weather and more daylight—it signals the beginning of allergy season. Sales of over-the-counter allergy medications are booming across the U.S. In 2021, the allergy category sold $3.6B across in-store and online channels, an increase of 8% compared to the previous year.  

As consumers flock to the shelves for their allergy medication, retailers need to ensure private label and big-name brands are in stock, in store. While online sales growth of allergy medication is outpacing in-store sales, it only accounts for 11% of category sales overall. For this category, a significant portion of consumers are still looking to the larger name-brands they trust as well as the private label alternatives.